Open AccessPrognostic Impact of Tumor Size on Pancreatic Neuroendocrine Tumor Recurrence May Have Racial Variance
Author(s) -
Rui Zheng-Pywell,
Amanda Fang,
Ahmad Mahmoud Alkashash,
Seifeldin Awad,
Sushanth Reddy,
Selwyn M. Vickers,
Martin J. Heslin,
Vikas Dudeja,
Herbert Chen,
J. Bart Rose
Publication year - 2021
Publication title -
pancreas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.061
H-Index - 104
eISSN - 1536-4828
pISSN - 0885-3177
DOI - 10.1097/mpa.0000000000001776
Subject(s) - medicine , neuroendocrine tumors , incidence (geometry) , hazard ratio , cohort , retrospective cohort study , population , oncology , gastroenterology , confidence interval , physics , environmental health , optics
The incidence of pancreatic neuroendocrine tumors (PNETs) has increased over the last decade. Black patients have worse survival outcomes. This study investigates whether oncologic outcomes are racially disparate at a single institution.